ATE172201T1 - Morphinan-derivate und medizinische verwendung - Google Patents

Morphinan-derivate und medizinische verwendung

Info

Publication number
ATE172201T1
ATE172201T1 AT93902520T AT93902520T ATE172201T1 AT E172201 T1 ATE172201 T1 AT E172201T1 AT 93902520 T AT93902520 T AT 93902520T AT 93902520 T AT93902520 T AT 93902520T AT E172201 T1 ATE172201 T1 AT E172201T1
Authority
AT
Austria
Prior art keywords
medical uses
nch3
morphinane derivatives
morphinane
derivatives
Prior art date
Application number
AT93902520T
Other languages
English (en)
Inventor
Hiroshi Nagase
Koji Kawai
Kuniaki Kawamura
Jun Hayakawa
Takashi Endo
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Application granted granted Critical
Publication of ATE172201T1 publication Critical patent/ATE172201T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Fertilizers (AREA)
AT93902520T 1992-01-23 1993-01-22 Morphinan-derivate und medizinische verwendung ATE172201T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1011592 1992-01-23
JP29430892 1992-11-02

Publications (1)

Publication Number Publication Date
ATE172201T1 true ATE172201T1 (de) 1998-10-15

Family

ID=26345314

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902520T ATE172201T1 (de) 1992-01-23 1993-01-22 Morphinan-derivate und medizinische verwendung

Country Status (15)

Country Link
US (2) US6323212B1 (de)
EP (2) EP0846694A1 (de)
JP (1) JP2525552B2 (de)
KR (1) KR970011390B1 (de)
AT (1) ATE172201T1 (de)
AU (2) AU666702B2 (de)
CA (1) CA2105072C (de)
DE (1) DE69321525T2 (de)
DK (1) DK0577847T3 (de)
ES (1) ES2121988T3 (de)
FI (1) FI106126B (de)
NO (1) NO302755B1 (de)
NZ (1) NZ246687A (de)
TW (1) TW332814B (de)
WO (1) WO1993015081A1 (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69321525T2 (de) * 1992-01-23 1999-03-04 Toray Industries, Inc., Tokio/Tokyo Morphinan-derivate und medizinische verwendung
KR950702833A (ko) * 1993-06-30 1995-08-23 마에다 가쓰노스케 진해제(Antitussive)
DE69414085T2 (de) * 1993-07-19 1999-03-18 Toray Industries, Inc., Tokio/Tokyo Wirkstoff zum schutze von gehirnzellen
EP0663401B1 (de) * 1993-07-23 2000-06-07 Toray Industries, Inc. Morphinan-derivate und ihre medizinische verwendung
SE9401727D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds I
DE19602962A1 (de) * 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
EP0829481A1 (de) * 1996-09-16 1998-03-18 Pfizer Inc. Morphinan-Hydroxamsäure-Derivate
ATE359076T1 (de) * 1996-11-25 2007-05-15 Toray Industries Mittel gegen juckreiz
AU743929B2 (en) * 1997-03-27 2002-02-07 Toray Industries, Inc. Morphinane derivatives and medicinal use thereof
KR100514963B1 (ko) * 1997-07-11 2005-09-15 도레이 가부시끼가이샤 4,5-에폭시모르피난 유도체를 함유하는 안정한 의약품 조성물
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
EP0996434A4 (de) * 1997-07-14 2001-10-10 Adolor Corp Kappa-rezeptor agonisten enthaltende antipruritische arzneimittel und verfahren zur behandlung von pruritis
AU6117298A (en) * 1997-07-25 1999-02-16 Toray Industries, Inc. Hyponatremia remedies
US6583151B2 (en) 1997-09-02 2003-06-24 Toray Industries, Inc. Remedies for drug addiction
US6083944A (en) * 1997-10-07 2000-07-04 Cephalon, Inc. Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
TW570920B (en) * 1998-12-22 2004-01-11 Janssen Pharmaceutica Nv 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
CA2383146C (en) * 1999-08-24 2010-11-16 Hiroshi Nagase Therapeutic agent for neuropathic pain and neuropathic pain animal model
US6688746B2 (en) * 1999-12-03 2004-02-10 Iouri Malov Field testing using spread spectrum technique
WO2001074819A1 (en) * 2000-04-03 2001-10-11 Toray Industries, Inc. Analgesics containing morphinan n-oxide derivatives as the active ingredient
JP4453254B2 (ja) * 2001-03-30 2010-04-21 東レ株式会社 レストレス・レッグズ症候群治療薬
WO2002080918A1 (en) * 2001-04-02 2002-10-17 Toray Industries, Inc. Remedial or prophylactic agent for frequent urination or urinary incontinence
DE10161963A1 (de) * 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
AU2003234621A1 (en) 2002-05-17 2003-12-02 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
CN100537573C (zh) 2002-10-09 2009-09-09 东丽株式会社 尿频或尿失禁的治疗或预防剂以及具有含氮环状取代基的吗啡烷衍生物
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP1628664A4 (de) * 2003-06-04 2008-11-05 Alkermes Inc Polymorphe formen von naltrexon
DK1758452T3 (en) * 2004-05-28 2017-05-01 Human Biomolecular Res Inst METABOLIC STABLE ANALGETICS AND Painkillers
PE20060723A1 (es) * 2004-11-04 2006-08-29 Toray Industries Derivados de morfina como agentes analgesicos
KR101333620B1 (ko) * 2005-04-06 2013-11-27 도레이 카부시키가이샤 모르피난 유도체의 결정 및 그 제조법
ES2307352B1 (es) * 2005-04-12 2009-09-18 Bti, I+D, S.L. Implante dental y piezas destinadas a ser conectadas a un implante dental, y la conexion interna entre el implante dental y cada pieza.
US8183376B2 (en) * 2006-04-21 2012-05-22 Nektar Therapeutics Stereoselective reduction of a morphinone
CA2685126C (en) 2007-04-24 2015-04-14 Toray Industries, Inc. Therapeutic or prophylactic agent for dyskinesia
PT2151241E (pt) 2007-04-26 2012-05-07 Toray Industries Preparação sólida estável compreendendo um derivado de 4,5-epoximorfinano
PL2168580T3 (pl) * 2007-06-22 2016-06-30 Toray Industries Środek do leczenia lub zapobiegania schizofrenii
ES2748274T3 (es) 2007-10-05 2020-03-16 Toray Industries Remedio para aliviar los problemas de la piel que comprende un derivado de morfinano o una sal de adición de ácido farmacológicamente aceptable del mismo como el principio activo
WO2009103004A1 (en) * 2008-02-14 2009-08-20 Alkermes, Inc. Selective opioid compounds
WO2010006299A1 (en) * 2008-07-11 2010-01-14 Regents Of The University Of Minnesota Analgesic agents
MX2011004307A (es) 2008-10-24 2011-07-28 Toray Industries Tableta estable conteniendo derivado de 4,5-epoximorfinano.
CN102325777B (zh) * 2009-02-23 2015-08-12 马林克罗特公司 (+)-吗啡喃*n-氧化物及其制备方法
US8563724B2 (en) * 2009-02-23 2013-10-22 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
JP5784507B2 (ja) * 2009-02-23 2015-09-24 マリンクロッド エルエルシー （＋）−モルフィナニウム第四級塩およびその生成方法
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
JP5680069B2 (ja) * 2009-06-11 2015-03-04 マリンクロッド エルエルシー 触媒的水素移動による６−ケトノルモルフィナンの還元アミノ化
PL2440562T3 (pl) * 2009-06-11 2017-07-31 Mallinckrodt Llc Otrzymywanie 6-alfa-amino-N-podstawionych morfinanów w wyniku katalitycznego przeniesienia wodoru
WO2011009020A2 (en) 2009-07-16 2011-01-20 Mallinckrodt Inc. Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
US10363251B2 (en) 2009-07-16 2019-07-30 Mallinckrodt Llc (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
AU2011211223B2 (en) 2010-01-29 2014-10-23 Toray Industries, Inc. Therapeutic or prophylactic agent for biliary diseases
EP2580218B1 (de) 2010-06-11 2015-02-25 Rhodes Technologies Verfahren zur n-dealkylierung von tertiären aminen
CA2802295C (en) 2010-06-11 2016-09-20 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
AU2010357625B2 (en) 2010-07-16 2015-04-23 Mallinckrodt Llc (+)-morphinans as antagonists of Toll-like receptor 9 and therapeutic uses thereof
CA2814795C (en) 2010-10-19 2018-02-27 Memorial Sloan-Kettering Cancer Center 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain
WO2012105475A1 (ja) 2011-01-31 2012-08-09 東レ株式会社 悪液質の治療又は予防剤
KR20140036215A (ko) 2011-06-09 2014-03-25 말린크로트 엘엘씨 촉매 수소 전달에 의한 6-케토 모르피난의 환원 아미노화
AU2012304484B2 (en) 2011-09-08 2016-07-28 SpecGx LLC Production of alkaloids without the isolation of intermediates
ES2750640T3 (es) * 2012-08-16 2020-03-26 Scripps Research Inst Ligandos opioides kappa novedosos
TWI449704B (zh) * 2013-04-26 2014-08-21 Everlight Chem Ind Corp 嗎啡喃衍生物之結晶、其製造方法、及使用其之醫藥組成物
EP3077398B1 (de) 2013-12-05 2020-03-11 The University of Bath Neuartige opioidverbindungen und deren verwendungen
JP2015166331A (ja) * 2014-05-14 2015-09-24 遼東化学工業株式会社 ナルフラフィンの結晶およびその製造方法
JPWO2016152953A1 (ja) * 2015-03-24 2018-01-11 東レ株式会社 モルヒナン誘導体及びその医薬用途
CA2983314C (en) 2015-04-30 2024-11-12 Memorial Sloan-Kettering Cancer Center Mitragynine analogues and their uses
EA201891054A1 (ru) 2015-10-29 2018-10-31 Юниверсити Оф Цукуба Морфинановое производное и его медицинское применение
CA3018750A1 (en) 2016-03-22 2017-09-28 Regents Of The University Of Minnesota Combination for treating pain
EP3458061B1 (de) * 2016-05-19 2023-01-18 Virginia Commonwealth University Potente und selektive mu-opioid-rezeptor-modulatoren
JP6814470B2 (ja) 2017-02-10 2021-01-20 国立大学法人 筑波大学 モルヒナン誘導体
US20210000740A1 (en) * 2018-02-27 2021-01-07 Delpor, Inc. Compositions for small molecule therapeutic agent compounds
PL3761982T3 (pl) 2018-03-08 2025-03-17 Victoria Link Ltd Zastosowanie nalfurafiny w leczeniu chorób demielinizacyjnych
WO2020205735A1 (en) * 2019-03-29 2020-10-08 Humanwell Pharmaceutical US Novel morphinans useful for treating medical disorders
US11613547B2 (en) * 2019-07-08 2023-03-28 University Of Health Sciences & Pharmacy In St. Louis G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment
AU2020360928A1 (en) 2019-09-30 2022-04-14 Nippon Chemiphar Co., Ltd. Azepan derivative
EP4049658A4 (de) 2019-10-24 2023-11-22 Toray Industries, Inc. Therapeutischer oder prophylaktischer wirkstoff gegen kachexie
AU2021298446A1 (en) * 2020-06-30 2023-02-09 Toray Industries, Inc. Ameliorating agent or prophylactic agent for muscle weakness symptom in disease or syndrome associated with metabolic disorder
CN115181109B (zh) * 2021-04-02 2024-06-04 南京正大天晴制药有限公司 吗啡喃衍生物的晶体及其制备方法
KR20240001121A (ko) 2021-04-23 2024-01-03 도레이 카부시키가이샤 그렐린 저항성을 수반하는 악액질의 치료제 또는 예방제
JP7728367B2 (ja) 2021-06-14 2025-08-22 スコーピオン・セラピューティクス・インコーポレイテッド がんを処置するために使用され得る尿素誘導体
CN115960108B (zh) * 2021-10-09 2026-02-03 山东新时代药业有限公司 一种无定型盐酸纳呋拉啡及其制备方法
JPWO2023190665A1 (de) * 2022-03-29 2023-10-05

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL290054A (de)
US3236851A (en) * 1966-02-22 Unsaturated morphinan derivatives
DE622231C (de) * 1934-03-09 1935-11-23 Hermann Fischer Dr Verfahren zur Herstellung von Diacetylmorphin
GB864107A (en) 1958-09-10 1961-03-29 Albert Boehringer Morphine derivatives
GB919311A (en) 1958-10-29 1963-02-20 T & H Smith Ltd Derivatives of 14-hydroxycodeine and their preparation
DE2254298A1 (de) 1972-11-06 1974-05-16 Boehringer Sohn Ingelheim Neue (heteroarylmethyl)-normorphine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
GB1593191A (en) 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
GB1587831A (en) * 1977-03-23 1981-04-08 Reckitt & Colmann Prod Ltd Morphine derivatives
US4362870A (en) * 1980-01-16 1982-12-07 Regents Of The University Of Minnesota Selective opioid receptor alkylating agents
JPS574991A (en) 1980-06-10 1982-01-11 Sankyo Co Ltd Cyclopropylmethylnormorphine-6-sulfuric ester
US4401672A (en) 1981-10-13 1983-08-30 Regents Of The University Of Minnesota Non-addictive narcotic antitussive preparation
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
US4767718A (en) * 1984-06-18 1988-08-30 Southern Illinois University Foundation Fluorescent opioid reagents and methods of use thereof in the detection of opioid receptors
IN163125B (de) 1985-01-08 1988-08-13 Alkaloida Vegyeszeti Gyar
DE3617182A1 (de) 1985-05-23 1986-11-27 Sandoz-Patent-GmbH, 79539 Lörrach Morphinan-derivate
HU196376B (en) 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
US4730048A (en) 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates
US4806556A (en) 1985-12-12 1989-02-21 Regents Of The University Of Minnesota Gut-selective opiates
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
JPH01149788A (ja) 1987-12-08 1989-06-12 Chugai Pharmaceut Co Ltd 新規なモルヒネ誘導体
FR2636330B1 (fr) 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
US5219861A (en) * 1988-12-21 1993-06-15 Chugai Seiyaku Kabushiki Kaisha 6 β-Thiomorphine derivatives
EP0374919A1 (de) 1988-12-21 1990-06-27 Chugai Seiyaku Kabushiki Kaisha Morphinderivat
US5258386A (en) * 1991-06-05 1993-11-02 The United States Of America As Represented By The Secretary Of The Army (+)-3-substituted-N alkylmorphinans, synthesis and use as anticonvulsant and neuroprotective agents
DE69321525T2 (de) * 1992-01-23 1999-03-04 Toray Industries, Inc., Tokio/Tokyo Morphinan-derivate und medizinische verwendung
KR950702833A (ko) * 1993-06-30 1995-08-23 마에다 가쓰노스케 진해제(Antitussive)

Also Published As

Publication number Publication date
US6323212B1 (en) 2001-11-27
AU4067195A (en) 1996-03-07
NO302755B1 (no) 1998-04-20
JP2525552B2 (ja) 1996-08-21
FI934144A0 (fi) 1993-09-22
DE69321525T2 (de) 1999-03-04
TW332814B (en) 1998-06-01
AU686483B2 (en) 1998-02-05
AU3367193A (en) 1993-09-01
ES2121988T3 (es) 1998-12-16
CA2105072A1 (en) 1993-07-24
DK0577847T3 (da) 1999-06-23
EP0577847A1 (de) 1994-01-12
CA2105072C (en) 1998-07-28
EP0577847A4 (de) 1994-12-07
WO1993015081A1 (en) 1993-08-05
EP0846694A1 (de) 1998-06-10
NZ246687A (en) 1996-12-20
JPH08502275A (ja) 1996-03-12
EP0577847B1 (de) 1998-10-14
DE69321525D1 (de) 1998-11-19
KR970011390B1 (ko) 1997-07-10
FI934144L (fi) 1993-09-22
NO933376L (no) 1993-09-23
US6277859B1 (en) 2001-08-21
NO933376D0 (no) 1993-09-22
FI106126B (fi) 2000-11-30
AU666702B2 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
ATE172201T1 (de) Morphinan-derivate und medizinische verwendung
NO941101D0 (no) Quinazolin-derivater
KR960702464A (ko) Dc-89 유도체[dc-89 derivative]
ATE116306T1 (de) Hypoglykämische oxazolidindion-derivate.
DE69023171D1 (de) Kondensierte heterozyklische Verbindungen, ihre Herstellung und Verwendung.
ATE247654T1 (de) Neue heterozyklische verbindungen
DE69428977D1 (de) Arzneimittel gegen Parkinsonsche Krankheit
FI943142A0 (fi) Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt
DE69505470D1 (de) Pyrrolocarbazol
YU46998B (sh) Postupak za dobijanje derivata cefema i medjuproizvoda za iste
NO944371L (no) Kjemisk forbindelse med blodplateaggregeringsinhibiotoraktivitet
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
DK147588D0 (da) Benzoxazinderivat samt fremgangsmaade til fremstilling deraf
FI906021A0 (fi) Oxetanderivat, framstaellning av dessa samt anvaendning som svampmotverkande eller foerstoerande aemnen.
ATE55057T1 (de) Zentralwirkende muskelrelaxante.
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
PT99250A (pt) Processo para a preparacao de derivados de piperazina
JPS56131571A (en) Novel hetero ring substituted carboxyamide and methyl amine compound
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.
IT1204960B (it) Composti dotati di attivita' antiallergica
IT1204959B (it) Composti dotati di attivita' antiallergica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification